1st Quarter - Report

PKD FOUNDATION for PKD FOUNDATION

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

PKD research in the Department of Defense Peer-Reviewed Medical Reserach Program and the Congressionally Directed Medical Research Programs

LobbyistCovered position, as disclosed
KIMBERLY CANTOR —
DAN E LARSON —

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Health Issues HCR

Ask for co-sponsorship and support for the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)

LobbyistCovered position, as disclosed
KIMBERLY CANTOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH)

Bills named: H.R. 1458 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.